Implementation and monitoring of decisions by pharmacy and therapeutics committees in South African public sector hospitals

References

• Gauteng Province Department of Health. Guidelines for Implementation of Pharmaceutical and Therapeutics Committees (PTCs) in Gauteng province. 1st ed. Pretoria; 2013 [cited 2018 Oct 31]. Available from: http://siapsprogram.org/publication/guidelines-for-implementation-of-pharmaceutical-and-therapeutics-committees-in-gauteng-province/.
   Google Scholar
• National Department of Health. National Drug Policy for South Africa. Cape Town: CTP Printers; 1996 [cited 2018 Oct 31]. Available from: http://apps.who.int/medicinedocs/documents/s17744en/s17744en.pdf.
   Google Scholar
• Bjorkhem-Bergman L, Andersen-Karlsson E, Laing R, et al. Interface management of pharmacotherapy. Joint hospital and primary care drug recommendations. Eur J Clin Pharmacol. 2013;69 Suppl 1:73–78.
   PubMed Web of Science ®Google Scholar
• Gustafsson LL, Wettermark B, Godman B, et al. The ‘wise list’- a comprehensive concept to select, communicate and achieve adherence to recommendations of essential drugs in ambulatory care in Stockholm. Basic Clin Pharmacol Toxicol. 2011;108(4):224–233.
   PubMed Web of Science ®Google Scholar
• Godman B, Shrank W, Andersen M, et al. Policies to enhance prescribing efficiency in Europe: findings and future implications. Front Pharmacol. 2010;1:141.
   PubMed Web of Science ®Google Scholar
• Lima-Dellamora E, Caetano R, Gustafsson LL, et al. An analytical framework for assessing drug and therapeutics committees structure and work processes in tertiary Brazillian hospitals. Basic Clin Pharmacol Toxicol. 2014;115:268–276.
   PubMed Web of Science ®Google Scholar
• Fadare JO, Oshikoya KA, Ogunleye OO, et al. Drug promotional activities in Nigeria: impact on the prescribing patterns and practices of medical practitioners and the implications. Hosp Pract. 2018;46(2):77–87.
   PubMedGoogle Scholar
• Civaner M. Sale strategies of pharmaceutical companies in a “pharmerging” country: the problems will not improve if the gaps remain. Health Policy. 2012;106(3):225–232.
   PubMed Web of Science ®Google Scholar
• Wall LL, Brown D. The high cost of free lunch. Obstet Gynecol. 2007;110(1):169–173.
   PubMed Web of Science ®Google Scholar
• Datta A, Dave D. Effects of physician-directed pharmaceutical promotion on prescription behaviors: longitudinal evidence. Health Economics. 2017;26(4):450–468.
   PubMed Web of Science ®Google Scholar
• Spurling GK, Mansfield PR, Montgomery BD, et al. Information from pharmaceutical companies and the quality, quantity, and cost of physicians’ prescribing: a systematic review. PLoS Medicine. 2010;7(10):e1000352.
   PubMed Web of Science ®Google Scholar
• Strengthening Pharmaceutical Systems (SPS) South Africa. Promoting the rational use of medicines through pharmaceutical and therapeutics committees in South Africa: results, challenges, and way forward. Submitted to the US agency for international development by the Strengthening Pharmaceutical Systems (SPS) Program. Arlington VA: Management Sciences for Health,; 2012.
   Google Scholar
• National Department of Health (NDoH). National policy for the establishment and functioning of pharmaceutical and therapeutics committees in South Africa. [cited 2018 Jun 13]. Available from: http://www.health.gov.za/idex.php/pharmaceutical-and-therapeutics-committees
   Google Scholar
• Matlala M, Gous AGS, Godman B, et al. Structure and activities of pharmacy and therapeutics committees among public hospitals in South Africa: findings and implications. Expert Rev Clin Pharmacol. 2017;10(11):1273–1280.
   PubMed Web of Science ®Google Scholar
• Schellack N, Dlamini DN, Meyer JC, et al. Point prevalence survey of antimicrobial utilisation in an academic hospital in the Gauteng province, South Africa. Medicines Utilisation Research in Africa (MURIA). Third Training Workshop and Symposium; 2017 Jun 26–28; Windhoek, Namibia. [ cited 2018 Oct 31]. Available from: http://muria.mandela.ac.za/muria/media/Store/documents/Abstract%20book%20-%20MURAI%203/MURIA3-AbstractBook-July-2017.pdf
   Google Scholar
• van der Sandt N, Schellack N, Mabope LA, et al. Surgical antimicrobial prophylaxis among pediatric patients in South Africa comparing two healthcare settings. Pediatr Infect Dis J. 2018 Apr 19;1. DOI:10.1097/INF.0000000000002072.
   PubMed Web of Science ®Google Scholar
• Messina AP, van Den Bergh D, Goff DA. Antimicrobial stewardship with pharmacist intervention improves timeliness of antimicrobials across thirty-three hospitals in South Africa. Infect Dis Ther. 2015 Sep;4(Suppl 1):5–14.
   PubMedGoogle Scholar
• Strengthening Pharmaceutical Systems (SPS) South Africa. Promoting the rational use of medicines through pharmaceutical and therapeutics committees in South Africa: results, challenges, and way forward. Submitted to the US Agency for International Development by the Strengthening Pharmaceutical Systems (SPS) Program. Arlington, VA: Management Sciences for Health; 2012.
   Google Scholar
• Meyer JC, Schellack N, Stokes J, et al. Ongoing initiatives to improve the quality and efficiency of medicine use within the public healthcare system in South Africa; a preliminary study. Front Pharmacol. 2017;8:751. .
   PubMed Web of Science ®Google Scholar
• Mittmann N, Knowles S. A survey of pharmacy and therapeutic committees across Canada: scope and responsibilities. J Clin Pharmacol. 2009;16(1):171–177.
   Google Scholar
• Hoffmann M. The right drug, but from whose perspective? A framework for analysing the structure and activities of drug and therapeutics committees. Eur J Clin Pharmacol. 2013;69(Suppl 1):79–87.
   PubMedGoogle Scholar
• Vang C, Tomson G, Kounnavong S, et al. Improving the performance of drug and therapeutics committees in hospitals-a quasi-experimental study in Laos. Eur J Clin Pharmacol. 2006;62:57–63.
   PubMed Web of Science ®Google Scholar
• Terblanche A, Meyer JC, Godman B, et al. Knowledge, attitudes and perspective on adverse drug reaction reporting in a public sector hospital in South Africa: baseline analysis. Hosp Pract (1995). 2017;45(5):238–245.
   PubMedGoogle Scholar
• Terblanche A, Meyer JC, Godman B, et al. Impact of a pharmacist-driven pharmacovigilance system in a secondary hospital in the Gauteng province of South Africa. Hosp Pract. 2018;46(4):221–228.
   PubMedGoogle Scholar
• Naicker P, Schellack N, Godman B, et al. Creating and evaluating an opportunity for medication reconciliation in the adult population of South Africa to improve patient care. Hosp Pract. 2018;46(3):110–120.
   PubMedGoogle Scholar
• Farmer BM, Nelson LS. Conflicts of interest on pharmacy and therapeutics committees at academic medical centres. J Med Toxicol. 2011;7:175–176.
   PubMedGoogle Scholar
• Miralles M. Managing access-to medicines and health technologies. MDS-3rd ed. Arlington, VA: Management Sciences for Health; 2012. Chapter 48, Monitoring and evaluation. p. 48.2–48.16.
   Google Scholar
• Management Sciences for Health, World Health Organization (MSH, WHO). Drug and therapeutics committee training course. Submitted to the U.S. agency for international development by the rational pharmaceutical management plus program. Arlington, VA: Management Sciences for Health; 2007 [cited 2018 Nov 1]. Available from: www.who.int/medicines/technical_briefing/tbs/Trainer-s-Guide-All-Sessions.pdf.
   Google Scholar
• Tan EL, Day RO, Brien JE. Prioritising Drug and Therapeutics Committee (DTC) decisions: a national survey. Pharm World Sci. 2007;29:90–96.
   PubMed Web of Science ®Google Scholar
• Watt SC, Simpson C, McKillop C, et al. Electronic course surveys: does automating feedback and reporting give better results? Assess Eval High Educ. 2002;27(4):325–337.
   Google Scholar
• Eriksen J, Ovesjo ML, Vallin M, et al. Primary care physicians report high trust in and usefulness of the Stockholm drug and therapeutic committee’s list of recommended essential medicines (the ‘Wise List’). Eur J Clin Pharmacol. 2018;74(1):131–138.
   PubMed Web of Science ®Google Scholar
• MS ParerEighteenth annual conference of the Higher Education Research Society of Australasia. 1992 July 7–10. held at Monash University Gippsland Campus, Churchill Victoria.
   Google Scholar
• Plet HT, Hallas J, Nielsen GS, et al. Drug and therapeutics committees in Danish hospitals: a survey of organisation, activities and drug selection procedures. Basic Clin Pharmacol Toxicol. 2013;112:264–269.
   PubMed Web of Science ®Google Scholar
• Hassali MA, Kamil TK, Md Yusof FA, et al. General practitioners’ knowledge, attitude and prescribing of antibiotics for upper respiratory tract infections in Selangor, Malaysia: findings and implications. Expert Rev Anti-Infect Ther. 2015;13(4):511–520.
   PubMed Web of Science ®Google Scholar
• Gul W. PTC is important for the betterment of the hospital pharmacy. IPP. 2014;2(1):307–311.
   Google Scholar
• Umnuaypornlert A, Kitikannakorn N. Performance of pharmacy and therapeutics committees of public hospitals in rural Thailand. Mahidol Univ J Pharm Sci. 2014;41(1):11–18.
   Google Scholar
• Nakwatumbah S, Kibuule D, Godman B, et al. Compliance to guidelines for the prescribing of antibiotics in acute infections at Namibia’s national referral hospital: a pilot study and the implications. Expert Rev Anti-Infect Ther. 2017;15(7):713–721.
   PubMed Web of Science ®Google Scholar
• Niaz Q, Godman B, Massele A, et al. Validity of World Health Organisation prescribing indicators in Namibia’s primary healthcare: findings and implications. Int J Qual Health Care. 2018;mzy172:1–8.
   Google Scholar
• Duran-Garcia E, Santos-Ramos B, Puigventos-Latorre F, et al. Literature review on the structure and operation of pharmacy and therapeutics committees. Int J Clin Pharm. 2011;33:475–483.
   PubMed Web of Science ®Google Scholar